PREVALENCE OF PLATELET DYSFUNCTION AND ITS ASSOCIATION WITH THROMBOTIC EVENTS IN PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION

Thanh Linh Tran1,2, , Huu Thien Bien Le1, Thi Ngoc Thao Pham2
1 University of Medicine and Pharmacy at Ho Chi Minh City
2 Cho Ray Hospital

Main Article Content

Abstract

Objectives: To determine the prevalence of platelet dysfunction and examine its association with thrombotic events in patients undergoing extracorporeal membrane oxygenation (ECMO). Methods: A single-center prospective cohort study was conducted on 54 ECMO patients aged ≥ 16 years at Cho Ray Hospital from March 2023 to March 2026. ECMO patients were enrolled, and platelet function was assessed using the PFA-200 (measuring Col/Epi and Col/ADP closure times) at four time points: before ECMO initiation (T0), at 24 hours (T1), 72 hours after ECMO initiation (T2), and 12 - 24 hours post-decannulation (T3). Results: Among the patients included in the study, thrombotic events occurred in 25 patients (46.3%). The overall rates of platelet dysfunction at T0, T1, T2 and T3 were 38.9%, 98.1%, 98.1% and 44.4%, respectively. Col/Epi and Col/ADP values increased during ECMO and decreased after ECMO decannulation. However, no statistically significant differences in Col/Epi or Col/ADP were observed between patients with and without thrombotic events across all the assessed time points. Conclusion: Platelet dysfunction is highly prevalent during ECMO support and decreases following decannulation. However, this study found no statistically significant association between platelet dysfunction and thrombotic events.

Article Details

References

1. Nunez JI, Gosling AF, O’Gara B, et al. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis. Intensive Care Med. 2022;48(2):213-24.
2. Jiritano F, Serraino GF, Ten Cate H, et al. Platelets and extra-corporeal membrane oxygenation in adult patients: a systematic review and meta-analysis. Intensive Care Med. 2020;46(6):1154-69.
3. Levy JH, Alexander PMA, Wolberg AS, et al. ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (a workshop report of the NHLBI). Blood Vessels Thromb Hemost. 2025;2(2):100064.
4. Garaj M, Francesconi A, Durila M, Vajter J, Holubová G, Hrachovinová I. ECMO produces very rapid changes in primary hemostasis detected by PFA-200 during lung transplantation: an observational study. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2024;43(11):1771-6.
5. Cartwright B, Bruce HM, Kershaw G, et al. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study. Sci Rep. 2021; 11(1):7975.
6. Extracorporeal life support organization. ELSO anticoagulation guideline. Published online 2014.
7. Frere C, Mazzeffi M, Maier CL, et al. Acquired von Willebrand syndrome during extracorporeal membrane oxygenation support: a comprehensive review of current evidence: communication from the ISTH SSC on perioperative and critical care thrombosis and hemostasis. J Thromb Haemost JTH. 2024;22(9):2608-28.
8. Hermann A, Krais J, Tremetsberger AM, et al. Cannula-Associated Deep Vein Thrombosis After Extracorporeal Life Support: a prospective diagnostic study. J Clin Med. 2025;14(20):7241.
9. Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med. 2018;5:352.